Copyright: Julien Behal
What You Should Know:
– Abbott, a global healthcare leader, has officially opened its new global manufacturing center of excellence for Abbott’s diabetes care business in Kilkenny, Ireland.
– Abbott’s FreeStyle Libre portfolio is…
Continue Reading
What You Should Know:
– Abbott announced that its FreeStyle Libre 2 and 3 continuous glucose monitoring (CGM) systems have received FDA clearance for use during common imaging procedures, including X-rays, CT scans, and MRIs.
–…
Continue Reading
The U.S. spends $413 billion dollars each year on diabetes-related care, meaning that diabetic patients now account for one of every four healthcare dollars spent in the country.
The first step in fixing this problem…
Continue Reading
What You Should Know:
– Ascensia Diabetes Care has announced the U.S. launch of the Eversense® 365 continuous glucose monitoring (CGM) system, an advancement in diabetes management.
– Developed by Senseonics Holdings, Inc., Eversense 365 is…
Continue Reading
Thousands of children and eligible adults living with type 1 diabetes across England will be able to receive an ‘artificial pancreas’ following cost-effective deals secured by the NHS with the technology’s suppliers.
The Hybrid Closed…
An interdisciplinary team of researchers from various Chinese universities have developed a miniature-sized continuous glucose monitoring system that works as effectively as market-leading systems.WHAT IT’S ABOUT
The CGM sensor is made of an organic electrochemical…
What You Should Know:
– DexCom, Inc., the global leader in real-time continuous glucose monitoring, and Beyond Type 2, a non-profit organization, are joining forces with actress Retta to launch the first-ever National Glucose Awareness…
Continue Reading
Respiree, Roche announces AI integration for RPMSingaporean startup Respiree has tied up with global pharmaceutical and diagnostics company Roche for technology integration.
Respiree will be combining its vital sign monitoring device with Roche’s blood glucose…
What You Should Know:
– A research study by CCS, a leading chronic care management company, reveals that patients receiving continuous glucose monitoring (CGM) devices through medical benefits experience superior adherence and lower costs compared…
Continue Reading
What You Should Know:
– Senseonics Holdings, Inc. and Ascensia Diabetes Care announced that the FDA has cleared the Eversense® 365 CGM system.
– This marks a significant advancement in diabetes management, offering a fully-implantable, long-term…
Continue Reading
